Inactive Instrument
IRLAB Therapeutics AB Stock Nasdaq Stockholm
Stocks
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 09-03 | Irlab CEO Kristina Torfgaard to step down in 2027 | FW |
| 09-03 | Irlab CEO Kristina Torfgaard wants to step down | FW |
| Market Cap | 272M 27.07M 24.05M 22.47M 20.49M 38.47M 2.6B 39.04M 105M 1.33B 101M 99.28M 4.31B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 272M 27.07M 24.05M 22.47M 20.49M 38.47M 2.6B 39.04M 105M 1.33B 101M 99.28M 4.31B | EV / Sales 2026 * |
2.68x | EV / Sales 2027 * | 1.9x |
| Free-Float |
83.4% | Yield 2026 * |
-
| Yield 2027 * | - |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 01/08/2024 | |
Susanna Waters
PRN | Corporate Officer/Principal | 60 | 01/01/2013 |
Clas Sonesson
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/01/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Rein Piir
BRD | Director/Board Member | 68 | 01/01/2016 |
| Chairman | 73 | 07/05/2020 | |
Veronica Wallin
BRD | Director/Board Member | 40 | 01/01/2023 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.62% | -0.10% | +50.70% | +114.07% | 1,031B | |
| -2.30% | -3.90% | +39.50% | +66.07% | 638B | |
| -0.63% | -1.94% | +12.26% | +74.38% | 462B | |
| -1.03% | -2.88% | +71.35% | +39.69% | 359B | |
| -0.03% | -3.91% | +34.28% | +39.35% | 335B | |
| -1.58% | +0.39% | +17.92% | +25.77% | 273B | |
| -2.02% | -3.20% | +7.60% | +8.38% | 253B | |
| -3.38% | +0.29% | +44.32% | +51.54% | 228B | |
| -1.04% | -2.56% | +32.88% | +96.82% | 185B | |
| Average | -0.69% | -0.36% | +34.53% | +57.34% | 418.21B | |
| Weighted average by Cap. | -0.21% | -0.35% | +38.05% | +69.18% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 101M 10.09M 8.96M 8.37M 7.64M 14.34M 970M 14.55M 39.19M 495M 37.82M 37M 1.6B | 143M 14.27M 12.68M 11.85M 10.81M 20.28M 1.37B 20.59M 55.46M 701M 53.51M 52.35M 2.27B |
| Net income | -36.1M -3.6M -3.2M -2.99M -2.72M -5.11M -346M -5.19M -13.98M -177M -13.49M -13.2M -572M | 34.6M 3.45M 3.06M 2.86M 2.61M 4.9M 332M 4.97M 13.4M 169M 12.93M 12.65M 549M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
Calendar
Select your edition
All financial news and data tailored to specific country editions
